Payment overview · 2025
General Payments
$115.16
1 reported records · 1 companies
Healthcare provider profile · identity verified
Rodney M Swenson, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · ANDERSON, CA · NPI 1407863913
Verified facts
What the public records show
CMS Open Payments records show Rodney M Swenson, D.O. received $115.16 in general payments during 2025 across 1 reported records.
Edwards Lifesciences Corporation accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Edwards Lifesciences Corporation | Unresolved — no canonical attribution shown | $115.16 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $115.16 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 631 | 91 |
| Atorvastatin Calcium | Atorvastatin Calcium | 530 | 154 |
| Lorazepam | Lorazepam | 423 | 68 |
| Losartan Potassium | Losartan Potassium | 414 | 119 |
| Levothyroxine Sodium | Levothyroxine Sodium | 354 | 99 |
| Amlodipine Besylate | Amlodipine Besylate | 329 | 103 |
| Hydrochlorothiazide | Hydrochlorothiazide | 242 | 77 |
| Metoprolol Succinate | Metoprolol Succinate | 220 | 69 |
| Omeprazole | Omeprazole | 219 | 67 |
| Eliquis | Apixaban | 204 | 37 |
| Potassium Chloride | Potassium Chloride | 198 | 65 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 176 | 59 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 165 | 18 |
| Gabapentin | Gabapentin | 164 | 49 |
| Metformin Hcl Er | Metformin Hcl | 164 | 54 |
| Tamsulosin Hcl | Tamsulosin Hcl | 160 | 52 |
| Zolpidem Tartrate | Zolpidem Tartrate | 146 | 23 |
| Mounjaro | Tirzepatide | 140 | 26 |
| Sertraline Hcl | Sertraline Hcl | 137 | 38 |
| Tramadol Hcl | Tramadol Hcl | 124 | 24 |
| Trazodone Hcl | Trazodone Hcl | 124 | 31 |
| Pantoprazole Sodium | Pantoprazole Sodium | 121 | 44 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 118 | 35 |
| Alprazolam | Alprazolam | 110 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 110 | 34 |
| Trulicity | Dulaglutide | 110 | 17 |
| Lisinopril | Lisinopril | 103 | 38 |
| Furosemide | Furosemide | 96 | 33 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 87 | 15 |
| Metformin Hcl | Metformin Hcl | 83 | 27 |
| Warfarin Sodium | Warfarin Sodium | 81 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 79 | 21 |
| Diazepam | Diazepam | 78 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 72 | 17 |
| Allopurinol | Allopurinol | 71 | 22 |
| Metoprolol Tartrate | Metoprolol Tartrate | 70 | 25 |
| Baclofen | Baclofen | 67 | 11 |
| Montelukast Sodium | Montelukast Sodium | 67 | 20 |
| Simvastatin | Simvastatin | 65 | 20 |
| Finasteride | Finasteride | 64 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 61 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 60 | 15 |
| Pregabalin | Pregabalin | 54 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 53 | 15 |
| Bupropion Xl | Bupropion Hcl | 50 | 14 |
| Carvedilol | Carvedilol | 49 | 14 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 48 | 12 |
| Famotidine | Famotidine | 47 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 47 | suppressed |
| Prednisone | Prednisone | 46 | 15 |
| Atenolol | Atenolol | 45 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 44 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 44 | 12 |
| Ondansetron Odt | Ondansetron | 43 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 42 | 13 |
| Spironolactone | Spironolactone | 40 | 12 |
| Xarelto | Rivaroxaban | 39 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 38 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 35 | suppressed |
| Estradiol | Estradiol | 35 | 12 |
| Ozempic | Semaglutide | 35 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 35 | 13 |
| Temazepam | Temazepam | 34 | suppressed |
| Glipizide | Glipizide | 33 | 11 |
| Azithromycin | Azithromycin | 32 | 27 |
| Cefuroxime | Cefuroxime Axetil | 32 | 25 |
| Ibuprofen | Ibuprofen | 32 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 32 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 32 | 26 |
| Valsartan | Valsartan | 32 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 31 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 30 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 29 | 21 |
| Amitriptyline Hcl | Amitriptyline Hcl | 28 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 27 | suppressed |
| Novolog Flexpen | Insulin Aspart | 27 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | 21 |
| Fluconazole | Fluconazole | 26 | 15 |
| Symbicort | Budesonide/Formoterol Fumarate | 26 | suppressed |
| Eszopiclone | Eszopiclone | 25 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 25 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 25 | suppressed |
| Clonazepam | Clonazepam | 24 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 24 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 24 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 24 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 23 | suppressed |
| Amoxicillin | Amoxicillin | 21 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 21 | suppressed |
| Bumetanide | Bumetanide | 20 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Tradjenta | Linagliptin | 20 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 19 | suppressed |
| Sucralfate | Sucralfate | 19 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 19 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | suppressed |
| Methocarbamol | Methocarbamol | 18 | suppressed |
| Acyclovir | Acyclovir | 17 | suppressed |
| Anastrozole | Anastrozole | 17 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | 13 |
| Paxlovid | Nirmatrelvir/Ritonavir | 17 | 17 |
| Topiramate | Topiramate | 17 | suppressed |
| Xopenex Hfa | Levalbuterol Tartrate | 17 | suppressed |
| Azathioprine | Azathioprine | 16 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 16 | suppressed |
| Sulfasalazine | Sulfasalazine | 16 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Entresto | Sacubitril/Valsartan | 15 | suppressed |
| Glipizide Er | Glipizide | 15 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 15 | suppressed |
| Lovastatin | Lovastatin | 15 | suppressed |
| Memantine Hcl | Memantine Hcl | 15 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 15 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Balsalazide Disodium | Balsalazide Disodium | 13 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 13 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 13 | suppressed |
| Humalog Kwikpen U-200 | Insulin Lispro | 13 | suppressed |
| Meloxicam | Meloxicam | 13 | suppressed |
| Synthroid | Levothyroxine Sodium | 13 | suppressed |
| Carisoprodol | Carisoprodol | 12 | suppressed |
| Cefdinir | Cefdinir | 12 | suppressed |
| Dofetilide | Dofetilide | 12 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Dutasteride | Dutasteride | 12 | suppressed |
| Fentanyl | Fentanyl | 12 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 12 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Testosterone | Testosterone | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Mirtazapine | Mirtazapine | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $115.16 · 1 records | Edwards Lifesciences Corporation | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error